An evaluation of HIV testing among inmates in the North Carolina prison system.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMC 2760001)

Published in Am J Public Health on October 01, 2009

Authors

David L Rosen1, Victor J Schoenbach, David A Wohl, Becky L White, Paul W Stewart, Carol E Golin

Author Affiliations

1: Schools of Public Health and Medicine, University of North Carolina, Chapel, Chapel Hill, NC, 27599-7435, USA.

Articles cited by this

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep (2006) 37.28

Self-reported health and prior health behaviors of newly admitted correctional inmates. Am J Public Health (2000) 5.13

Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health (2004) 3.32

Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol (1994) 2.81

Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.47

The importance of routine HIV testing in the incarcerated population: the Rhode Island experience. AIDS Educ Prev (2002) 1.91

HIV transmission among male inmates in a state prison system--Georgia, 1992-2005. MMWR Morb Mortal Wkly Rep (2006) 1.77

HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin. Am J Public Health (1990) 1.74

Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection. J Urban Health (2005) 1.54

HIV and AIDS surveillance among inmates in Maryland prisons. J Urban Health (2001) 1.52

HIV testing in correctional agencies and community treatment programs: the impact of internal organizational structure. J Subst Abuse Treat (2007) 1.21

HIV seroprevalence among male prison inmates in the Wisconsin Correctional System. WMJ (1998) 1.15

Young incarcerated men's perceptions of and experiences with HIV testing. Am J Public Health (2007) 0.97

Voluntary HIV testing in prison: do women inmates at high risk for HIV accept HIV testing? AIDS Educ Prev (1999) 0.88

Articles by these authors

Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30

Social context, sexual networks, and racial disparities in rates of sexually transmitted infections. J Infect Dis (2005) 5.73

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS (2007) 4.89

Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS (2007) 3.72

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49

Heterosexually transmitted HIV infection among African Americans in North Carolina. J Acquir Immune Defic Syndr (2006) 3.28

Concurrent sexual partnerships among men in the United States. Am J Public Health (2007) 3.27

HIV and African Americans in the southern United States: sexual networks and social context. Sex Transm Dis (2006) 3.18

Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. Clin Infect Dis (2010) 3.04

Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep (2005) 2.97

Sex with older partners is associated with primary HIV infection among men who have sex with men in North Carolina. J Acquir Immune Defic Syndr (2010) 2.89

Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med (2012) 2.81

Concurrent partnerships among rural African Americans with recently reported heterosexually transmitted HIV infection. J Acquir Immune Defic Syndr (2003) 2.74

Concurrent sexual partnerships among women in the United States. Epidemiology (2002) 2.74

Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr (2006) 2.65

Contextual factors and the black-white disparity in heterosexual HIV transmission. Epidemiology (2002) 2.59

Sexual behaviours of HIV-seropositive men and women following release from prison. Int J STD AIDS (2006) 2.58

Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst (2003) 2.52

Concurrent sexual partnerships among African Americans in the rural south. Ann Epidemiol (2004) 2.47

All-cause and cause-specific mortality among men released from state prison, 1980-2005. Am J Public Health (2008) 2.19

Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis (2003) 2.05

Cross-sectional associations of oral health measures with cognitive function in late middle-aged adults: a community-based study. J Am Dent Assoc (2013) 2.04

Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial. Pediatr Dermatol (2012) 2.00

How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med (2002) 1.84

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. Arch Intern Med (2007) 1.84

Incarceration and risky sexual partnerships in a southern US city. J Urban Health (2007) 1.83

Incarceration and high-risk sex partnerships among men in the United States. J Urban Health (2009) 1.83

Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr (2007) 1.76

Concurrent partnerships, nonmonogamous partners, and substance use among women in the United States. Am J Public Health (2010) 1.75

Putting prevention in their pockets: developing mobile phone-based HIV interventions for black men who have sex with men. AIDS Patient Care STDS (2013) 1.74

Preferences for medical collaboration: patient-physician congruence and patient outcomes. Patient Educ Couns (2005) 1.71

Ending the epidemic of heterosexual HIV transmission among African Americans. Am J Prev Med (2009) 1.69

Recommendations for planning pilot studies in clinical and translational research. Clin Transl Sci (2011) 1.67

Timing and duration of incarceration and high-risk sexual partnerships among African Americans in North Carolina. Ann Epidemiol (2008) 1.60

HIV acquisition among women from selected areas of the United States: a cohort study. Ann Intern Med (2013) 1.59

"It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Soc Sci Med (2009) 1.55

How new subscribers use cancer-related online mailing lists. J Med Internet Res (2005) 1.54

Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav (2011) 1.52

Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. J Acquir Immune Defic Syndr (2008) 1.51

Cigarette smoking, stress-induced analgesia and pain perception in men and women. Pain (2005) 1.47

Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr (2010) 1.47

Effect of a vascular endothelial cadherin antagonist in a rat lung transplant model. Ann Thorac Surg (2013) 1.43

A practical method to calibrate self-reported adherence to antiretroviral therapy. J Acquir Immune Defic Syndr (2006) 1.42

Efficacy of an adapted HIV and sexually transmitted infection prevention intervention for incarcerated women: a randomized controlled trial. Am J Public Health (2014) 1.42

Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy. PLoS Med (2006) 1.40

Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States). Cancer Causes Control (2006) 1.38

Serostatus disclosure to sexual partners among people living with HIV: examining the roles of partner characteristics and stigma. AIDS Care (2012) 1.38

Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5. Clin Pharmacol Ther (2005) 1.35

Disease prevalence and use of health care among a national sample of black and white male state prisoners. J Health Care Poor Underserved (2012) 1.34

Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients. AIDS (2007) 1.33

Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates. Clin Infect Dis (2003) 1.33

Sexual mixing patterns and heterosexual HIV transmission among African Americans in the southeastern United States. J Acquir Immune Defic Syndr (2009) 1.33

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS (2007) 1.29

Screening and assessment of coronary heart disease in HIV-infected patients. Circulation (2008) 1.29

Policies and politics that promote HIV infection in the Southern United States. AIDS (2014) 1.28

Challenges of a hidden epidemic: HIV prevention among women in the United States. J Acquir Immune Defic Syndr (2010) 1.27

HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep (2011) 1.25

Sex ratio, poverty, and concurrent partnerships among men and women in the United States: a multilevel analysis. Ann Epidemiol (2013) 1.24

Brief motivational interviewing to improve adherence to antiretroviral therapy: development and qualitative pilot assessment of an intervention. AIDS Patient Care STDS (2004) 1.21

Dissolution of primary intimate relationships during incarceration and associations with post-release STI/HIV risk behavior in a Southeastern city. Sex Transm Dis (2011) 1.20

Condom use and duration of concurrent partnerships among men in the United States. Sex Transm Dis (2009) 1.18

Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS. Int J Cancer (2005) 1.14

Dissolution of primary intimate relationships during incarceration and implications for post-release HIV transmission. J Urban Health (2011) 1.14

MACH14: a multi-site collaboration on ART adherence among 14 institutions. AIDS Behav (2013) 1.14

All-cause and cause-specific mortality among black and white North Carolina state prisoners, 1995-2005. Ann Epidemiol (2011) 1.13

CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults. J Appl Physiol (1985) (2003) 1.11

A marginalized zero-inflated Poisson regression model with overall exposure effects. Stat Med (2014) 1.11

Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex Transm Dis (2012) 1.10

Characteristics and behaviors associated with HIV infection among inmates in the North Carolina prison system. Am J Public Health (2009) 1.09

Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina. Pediatr Infect Dis J (2002) 1.09

Translating concern into action: HIV care providers' views on counseling patients about HIV prevention in the clinical setting. AIDS Behav (2007) 1.08

Systematic review: effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases. J Stud Alcohol Drugs (2012) 1.06

Growth failure in early life: an important manifestation of Turner syndrome. Horm Res (2002) 1.06

A method for fitting regression splines with varying polynomial order in the linear mixed model. Stat Med (2006) 1.05

Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care (2010) 1.05

Factors influencing adherence to antiretroviral therapy for HIV-infected female inmates. J Assoc Nurses AIDS Care (2009) 1.04

A targeted decision aid for the elderly to decide whether to undergo colorectal cancer screening: development and results of an uncontrolled trial. BMC Med Inform Decis Mak (2010) 1.02

Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression? Drug Metab Dispos (2004) 1.01

No evidence of an association between transient HIV viremia ("Blips") and lower adherence to the antiretroviral medication regimen. J Infect Dis (2004) 1.01

Motivational interviewing to support antiretroviral therapy adherence: the role of quality counseling. Patient Educ Couns (2005) 1.01

Multilevel challenges to engagement in HIV care after prison release: a theory-informed qualitative study comparing prisoners' perspectives before and after community reentry. BMC Public Health (2014) 1.01

Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr (2007) 1.01

Sexual risk behaviors among African-American and Hispanic women in five counties in the Southeastern United States: 2008-2009. Womens Health Issues (2011) 1.00

Family socioeconomic status and self-reported sexually transmitted diseases among black and white american adolescents. Sex Transm Dis (2004) 1.00

Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J Infect Dis (2002) 1.00

Retention strategies and factors associated with missed visits among low income women at increased risk of HIV acquisition in the US (HPTN 064). AIDS Patient Care STDS (2014) 0.99

Perceived everyday racism, residential segregation, and HIV testing among patients at a sexually transmitted disease clinic. Am J Public Health (2009) 0.99

Prediction of lung function response for populations exposed to a wide range of ozone conditions. Inhal Toxicol (2012) 0.98